These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2006-004476-12||A randomised open-label study comparing the safety and efficacy of three different combination antiretroviral regimens as initial therapy for HIV infection.||2011-12-11||bad-data|
|Not reported||2011-002107-15||A randomised, open label study to evaluate the efficacy and safety of maraviroc(MVC) as a switch for N(t)RTI or PI/r in HIV1 infected individuals with stable, well controlled plasma HIV RNA while taki...||2016-04-19||due-trials|
|Reported results||2015-000178-36||A phase II, open-label, single arm, multicentre, international trial of sofosbuvir and GS-5816 for people with chronic hepatitis C virus infection and recent injection drug use||2018-11-28||due-trials|
|Listed as ongoing, but also has a completion date||2015-004243-39||A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection.||2020-03-23||bad-data|
|Ongoing||2016-003724-23||Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT)||not-yet-due|
|Reported results||2017-000694-37||A phase IIIb, open-label, multicentre, international randomised controlled trial of simplified treatment monitoring for 8 weeks glecaprevir (300mg)/pibrentasvir (120mg) in chronic HCV treatment naïve ...||2018-12-14||due-trials|